The revenue result is real, but incomplete
OneRobotics, the Shenzhen home-robot maker listed in Hong Kong as 6600, reported first-half revenue of 522.4 million Chinese yuan, up 31.8 percent from 396.3 million yuan a year earlier. Gross profit also rose, by 22.5 percent to 263.1 million yuan. The company attributes the growth to commercial delivery of its onero H1 home humanoid and to the Acemate sports robot and Kata Friends companion robot, alongside faster sales in Europe and North America. Its filing says the three newer product lines generated 68.4 million yuan, or 65.4 percent of the year-on-year increase in home embodied-AI robot revenue.[1,2,3]
The disclosure supports a narrow commercial conclusion: products beyond the company’s earlier home-automation base are contributing revenue. It does not disclose unit deliveries, selling prices, named H1 customers, return rates or repeat purchasing. That matters because a reported launch and commercial delivery are not the same thing as a measured, self-sustaining home-robot business. OneRobotics’ own product documentation describes H1 as a mobile, dual-arm robot for household tasks, but the interim results do not provide an independently measured task-performance or customer-retention result for it.[1,3]
Margin and cash moved the other way
The top line did not translate cleanly into a stronger operating result. Gross margin fell to 50.4 percent from 54.2 percent, which the company attributes chiefly to weaker Japanese-yen and U.S.-dollar conversion into Chinese yuan. Research and development expense rose 73.3 percent to 101.7 million yuan, or 19.5 percent of revenue, from 14.8 percent a year earlier. Selling and distribution expense rose 62.9 percent to 174.1 million yuan, or 33.3 percent of revenue, versus 27.0 percent in the comparable half. OneRobotics recorded a 38.3 million yuan loss after reporting a 27.9 million yuan profit a year earlier.[1,2,3]
The loss was not simply a demand verdict. The filing records a 42.7 million yuan net foreign-exchange loss, against a 6.1 million yuan gain a year earlier, while the company’s forward contracts generated a 33.8 million yuan gain that only partly offset the exposure. The company also says the new categories are still in their market-introduction phase. Those explanations make the reported loss a poor shortcut for judging product demand, but they also show that greater overseas exposure is bringing currency, sales-channel and product-introduction costs before a durable margin outcome is visible.[1,2,3]
Growth tied up more cash than it released
The sharper change is in cash conversion. Operating activities used 164.7 million yuan in the first half, compared with generating 29.2 million yuan in the same period of 2025. OneRobotics attributes the reversal to a 100.1 million yuan increase in inventory for higher sales and new products, a 47.5 million yuan increase in trade receivables tied to overseas sales, and a 37.3 million yuan working-capital effect from lower contract liabilities and other payables. Higher trade payables offset part of the drain, but not enough to keep operating cash positive.[1,3]
This does not establish a near-term liquidity problem. Cash and bank balances were still 1.48 billion yuan at June 30, down 122.5 million yuan from year end, and the group also reported 118.0 million yuan in structured deposits. But the balance-sheet support has a specific context: the filing says the cash result was partly offset by 199.8 million yuan from a partial over-allotment of shares and new bank borrowings. Interest-bearing bank borrowings rose to 335.1 million yuan from 109.1 million yuan at the end of 2025, while the company’s stated debt-to-equity ratio increased to 24.9 percent from 14.0 percent.[1,3]
The next report needs to test conversion, not just demand
The useful reading of the half is therefore more demanding than a revenue-growth headline. OneRobotics has evidence that its newer robot portfolio and overseas channels are contributing sales, and the European and North American share of revenue rose to 42.1 percent from 28.8 percent. Yet the same expansion lowered margin, enlarged sales and research spending, and tied cash up in the operating cycle. The next measurable test is whether inventory and receivables convert into collected cash while gross margin holds, without a larger financing offset. Until the company discloses product-level deliveries, pricing or repeat customer evidence, the results show commercial momentum, not proven scale economics.[1,2,3]